跳到正文
原文
Science Magazine· @ScienceMagazine · X·· 4 天前精选AI 评分62
AI 导读

研究团队首次将受体基因疗法植入人脑,通过药物调控神经元活动,用于3名耐药性癫痫患者,抑制其海马区癫痫发作区域的神经活动。临床试验团队报告,该疗法未产生重大副作用,并似乎降低了癫痫发作发生率。

推荐理由

该试验把化学遗传学受体基因治疗用于耐药性癫痫患者,提供了人体安全性与发作减少的初步观察。

正文

Researchers have, for the first time, inserted receptors into the human brain that allow them to manipulate neuron activity with a drug.

The groundbreaking gene therapy was designed to help three people with drug-resistant epilepsy by dampening activity in the seizure-generating zones of their hippocampus.

The therapy did not produce major side effects, and appeared to reduce the incidence of seizures, the team conducting the clinical trial reported.

Learn more: https://scim.ag/4zkx35K @NewsfromScience

来源:Science Magazine · x.com